Pulmonary Hypertension

1: History of pulmonary hypertension and the circulation 2: Definitions of pulmonary hypertension and pulmonary arterial hypertension 3: Clinical classification of pulmonary hyptertension 4: Pathology of pulmonary hyptertension 5: Pathology of chronic thromboembolic pulmonary hypertension 6: Pathobiology of pulmonary arterial hypertension 7: Inflammation, growth factors and thrombosis in pulmonary arterial hypertension 8: Genetics and genomics of pulmonary arterial hypertension 9: Epidemiology of pulmonary arterial hypertension and pulmonary hypertension 10: Risk factors for pulmonary arterial hypertension 11: Pathophysiology of pulmonary hypertension in non-pulmonary arterial hypertension groups 12: Pulmonary arterial hypertension associated with connective tissue diseases 13: Systemic sclerosis 14: Systemic lupus erythematosus 15: Sjögren's syndrome 16: Polymyositis and dermatomyositis 17: HIV 18: Porto-pulmonary hypertension 19: Venous thromboembolism and acute pulmonary embolism 20: Acute pulmonary embolism 21: Chronic thromboembolic pulmonary hypertension 22: Pulmonary hypertension associated with congenital systemic-to-pulmonary cardiac shunts 23: Schistomiasis 24: Chronic haemolytic anaemias and pulmonary arterial hypertension 25: Interstitial lung disease and pulmonary hypertension 26: Prognosis of pulmonary arterial hypertension 27: The right ventricle 28: Clinical features of pulmonary arterial hypertension 29: Haemodynamics and treatment approaches in pulmonary hypertension due to left heart disease 30: Diagnostic algorithm 31: Simple investigations 32: Ventilation/perfusion scanning 33: Echocardiography 34: Non-invasive exercise testing 35: Cardiac catheterisation 36: Management of pulmonary arterial hypertension 37: General measures 38: Contraception in pulmonary arterial hypertension 39: Risks of pregnancy and contraception 40: Lifestyle issues 41: Elective surgery in patients with pulmonary arterial hypertension 42: Supportive therapy 43: Management of arrhythmias 44: Advanced therapies for pulmonary arterial hypertension 45: Endothelin and endothelin receptor antagonists 46: Phosphodiesterase-5 inhibitors 47: Classes of recommendations for procedures and treatments 48: Drug interactions with pulmonary arterial hypertension targeted therapies 49: Combination therapy in pulmonary arterial hypertension 50: Problems in conducting pulmonary arterial hypertension drug trials 51: Atrial septostomy 52: Translation